Circulating miR-15a and miR-222 as Potential Biomarkers of Type 2 Diabetes

References

• Schuster DP. Metabolic syndrome, targets o, therapy. Obesity and the development of type 2 diabetes: the effects of fatty tissue inflammation. Diabetes Metab Syndr Obes. 2010;3:253.
   PubMedGoogle Scholar
• Olokoba AB, Obateru OA, Olokoba LB. Type 2 diabetes mellitus: a review of current trends. Oman Med J. 2012;27(4):269.
   PubMedGoogle Scholar
• Chen L, Magliano DJ, Zimmet P. The worldwide epidemiology of type 2 diabetes mellitus—present and future perspectives. Nat Rev Endocrinol. 2012;8(4):228.
   Web of Science ®Google Scholar
• Guariguata L, Whiting DR, Hambleton I, Beagley J, Linnenkamp U, Shaw JE. Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pract. 2014;103(2):137–149. doi:10.1016/j.diabres.2013.11.002
   PubMed Web of Science ®Google Scholar
• Esteghamati A, Larijani B, Aghajani MH, et al. Diabetes in Iran: prospective analysis from first nationwide diabetes report of National Program for Prevention and Control of Diabetes (NPPCD-2016). Sci Rep. 2017;7(1):1–10. doi:10.1038/s41598-017-13379-z
   PubMedGoogle Scholar
• Ambros V. microRNAs: tiny regulators with great potential. Cell. 2001;107(7):823–826. doi:10.1016/S0092-8674(01)00616-X
   PubMed Web of Science ®Google Scholar
• Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2009;136(2):215–233. doi:10.1016/j.cell.2009.01.002
   PubMed Web of Science ®Google Scholar
• Dumortier O, Hinault C, Van Obberghen E. MicroRNAs and metabolism crosstalk in energy homeostasis. Cell Metab. 2013;18(3):312–324. doi:10.1016/j.cmet.2013.06.004
   PubMed Web of Science ®Google Scholar
• Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116(2):281–297. doi:10.1016/S0092-8674(04)00045-5
   PubMed Web of Science ®Google Scholar
• Taylor DD, Gercel-Taylor C. MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. Gynecol Oncol. 2008;110(1):13–21. doi:10.1016/j.ygyno.2008.04.033
   PubMed Web of Science ®Google Scholar
• Tanaka M, Oikawa K, Takanashi M, et al. Down-regulation of miR-92 in human plasma is a novel marker for acute leukemia patients. PLoS One. 2009;4(5):e5532. doi:10.1371/journal.pone.0005532
   PubMed Web of Science ®Google Scholar
• Fernández-Hernando C, Ramírez CM, Goedeke L, Suárez Y. MicroRNAs in metabolic disease. Arterioscler Thromb Vasc Biol. 2013;33(2):178–185. doi:10.1161/ATVBAHA.112.300144
   PubMed Web of Science ®Google Scholar
• Wang G-K, Zhu J-Q, Zhang J-T, et al. Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans. Eur Heart J. 2010;31(6):659–666. doi:10.1093/eurheartj/ehq013
   PubMed Web of Science ®Google Scholar
• Fichtlscherer S, De Rosa S, Fox H, et al. Circulating microRNAs in patients with coronary artery disease. Circ Res. 2010;107(5):677–684. doi:10.1161/CIRCRESAHA.109.215566
   PubMed Web of Science ®Google Scholar
• Schulze MB, Weikert C, Pischon T, et al. Use of multiple metabolic and genetic markers to improve the prediction of type 2 diabetes: the EPIC-Potsdam Study. Diabetes Care. 2009;32(11):2116–2119. doi:10.2337/dc09-0197
   PubMedGoogle Scholar
• Müller G. Microvesicles/exosomes as potential novel biomarkers of metabolic diseases. Diabetes Metab Syndr Obes. 2012;5:247. doi:10.2147/DMSO.S32923
   PubMedGoogle Scholar
• Dehghani MR, Zarch SMA, Mehrjardi MYV, et al. Evaluation of miR-181b and miR-126-5p expression levels in T2DM patients compared to healthy individuals: relationship with NF-κB gene expression. Endocrinol Diabetes Nutr. 2020;67(7):454–460. doi:10.1016/j.endinu.2019.09.009
   Google Scholar
• Kolberg JA, Jørgensen T, Gerwien RW, et al. Development of a type 2 diabetes risk model from a panel of serum biomarkers from the Inter99 cohort. Diabetes Care. 2009;32(7):1207–1212. doi:10.2337/dc08-1935
   PubMedGoogle Scholar
• Mitchell PS, Parkin RK, Kroh EM, et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci. 2008;105(30):10513–10518. doi:10.1073/pnas.0804549105
   PubMed Web of Science ®Google Scholar
• Chen X, Ba Y, Ma L, et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res. 2008;18(10):997–1006. doi:10.1038/cr.2008.282
   PubMed Web of Science ®Google Scholar
• Alevizos I, Illei GG. MicroRNAs as biomarkers in rheumatic diseases. Nat Rev Rheumatol. 2010;6(7):391. doi:10.1038/nrrheum.2010.81
   PubMed Web of Science ®Google Scholar
• Sebastiani G, Nigi L, Grieco G, Mancarella F, Ventriglia G, Dotta F. Circulating microRNAs and diabetes mellitus: a novel tool for disease prediction, diagnosis, and staging? J Endocrinol Invest. 2017;40(6):591–610. doi:10.1007/s40618-017-0611-4
   PubMed Web of Science ®Google Scholar
• Lagos-Quintana M, Rauhut R, Lendeckel W, Tuschl T. Identification of novel genes coding for small expressed RNAs. Science. 2001;294(5543):853–858. doi:10.1126/science.1064921
   PubMed Web of Science ®Google Scholar
• Aghaei M, Khodadadian A, Elham K-N, Nazari M, Babakhanzadeh E. Major miRNA involved in insulin secretion and production in beta-cells. Int J Gen Med. 2020;13:89.
   PubMed Web of Science ®Google Scholar
• Zampetaki A, Kiechl S, Drozdov I, et al. Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes. Circ Res. 2010;107(6):810–817. doi:10.1161/CIRCRESAHA.110.226357
   PubMed Web of Science ®Google Scholar
• Kong L, Zhu J, Han W, et al. Significance of serum microRNAs in pre-diabetes and newly diagnosed type 2 diabetes: a clinical study. Acta Diabetol. 2011;48(1):61–69. doi:10.1007/s00592-010-0226-0
   PubMed Web of Science ®Google Scholar
• Karolina DS, Tavintharan S, Armugam A, et al. Circulating miRNA profiles in patients with metabolic syndrome. J Clin Endocrinol Metab. 2012;97(12):E2271–E2276. doi:10.1210/jc.2012-1996
   PubMed Web of Science ®Google Scholar
• Yang Z, Chen H, Si H, et al. Serum miR-23a, a potential biomarker for diagnosis of pre-diabetes and type 2 diabetes. Acta Diabetol. 2014;51(5):823–831.
   PubMed Web of Science ®Google Scholar
• Chamberlain JJ, Rhinehart AS, Shaefer CF, Neuman A. Diagnosis and management of diabetes: synopsis of the 2016 American Diabetes Association Standards of Medical Care in Diabetes. Ann Intern Med. 2016;164(8):542–552. doi:10.7326/M15-3016
   PubMed Web of Science ®Google Scholar
• World Medical Association. Declaration of Helsinki. Law Medicine Healthc. 1991;19(3–4):264.
   PubMedGoogle Scholar
• Natali A, Baldi S, Bonnet F, et al. Plasma HDL-cholesterol and triglycerides, but not LDL-cholesterol, are associated with insulin secretion in non-diabetic subjects. Metabolism. 2017;69:33–42. doi:10.1016/j.metabol.2017.01.001
   PubMed Web of Science ®Google Scholar
• Flowers E, Gadgil M, Aouizerat BE, Kanaya AM. Circulating microRNAs associated with glycemic impairment and progression in Asian Indians. Biomarker Res. 2015;3(1):22. doi:10.1186/s40364-015-0047-y
   PubMedGoogle Scholar
• Sun -L-L, Jiang B-G, Li W-T, Zou -J-J, Shi Y-Q, Liu Z-M. MicroRNA-15a positively regulates insulin synthesis by inhibiting uncoupling protein-2 expression. Diabetes Res Clin Pract. 2011;91(1):94–100. doi:10.1016/j.diabres.2010.11.006
   PubMedGoogle Scholar
• Houshmand-Oeregaard A, Schrölkamp M, Kelstrup L, et al. Increased expression of microRNA-15a and microRNA-15b in skeletal muscle from adult offspring of women with diabetes in pregnancy. Hum Mol Genet. 2018;27(10):1763–1771. doi:10.1093/hmg/ddy085
   PubMed Web of Science ®Google Scholar
• Wang X, Sundquist J, Zöller B, et al. Determination of 14 circulating microRNAs in Swedes and Iraqis with and without diabetes mellitus type 2. PLoS One. 2014;9(1):e86792.
   PubMed Web of Science ®Google Scholar
• Shi Z, Zhao C, Guo X, et al. Differential expression of microRNAs in omental adipose tissue from gestational diabetes mellitus subjects reveals miR-222 as a regulator of ERα expression in estrogen-induced insulin resistance. Endocrinology. 2014;155(5):1982–1990. doi:10.1210/en.2013-2046
   PubMed Web of Science ®Google Scholar
• Ortega FJ, Mercader JM, Catalán V, et al. Targeting the circulating microRNA signature of obesity. Clin Chem. 2013;59(5):781–792. doi:10.1373/clinchem.2012.195776
   PubMed Web of Science ®Google Scholar
• Li M, Pan S, Qiu A. Roles of microRNA-221/222 in type 2 diabetic patients with post-menopausal breast cancer. Genet Mol Res. 2016;15(2).
   Google Scholar
• De Candia P, Spinetti G, Specchia C, et al. A unique plasma microRNA profile defines type 2 diabetes progression. PLoS One. 2017;12(12):e0188980. doi:10.1371/journal.pone.0188980
   PubMed Web of Science ®Google Scholar
• Meerson A, Najjar A, Saad E, Sbeit W, Barhoum M, Assy N. Sex differences in plasma microRNA biomarkers of early and complicated diabetes mellitus in Israeli Arab and Jewish Patients. Non-Coding RNA. 2019;5(2):32. doi:10.3390/ncrna5020032
   PubMedGoogle Scholar
• He Y, Ding Y, Liang B, et al. A systematic study of dysregulated microRNA in type 2 diabetes mellitus. Int J Mol Sci. 2017;18(3):456. doi:10.3390/ijms18030456
   PubMed Web of Science ®Google Scholar
• Wang K, Yuan Y, Cho J-H, McClarty S, Baxter D, Galas DJ. Comparing the MicroRNA spectrum between serum and plasma. PLoS One. 2012;7(7):e41561.
   PubMed Web of Science ®Google Scholar
• Al-Kafaji G, Al-Mahroos G, Alsayed NA, Hasan ZA, Nawaz S, Bakhiet M. Peripheral blood microRNA-15a is a potential biomarker for type 2 diabetes mellitus and pre-diabetes. Mol Med Rep. 2015;12(5):7485–7490. doi:10.3892/mmr.2015.4416
   PubMed Web of Science ®Google Scholar
• Higuchi C, Nakatsuka A, Eguchi J, et al. Identification of circulating miR-101, miR-375 and miR-802 as biomarkers for type 2 diabetes. Metabolism. 2015;64(4):489–497. doi:10.1016/j.metabol.2014.12.003
   PubMedGoogle Scholar
• Zhang T, Li L, Shang Q, Lv C, Wang C, Su B. Circulating miR-126 is a potential biomarker to predict the onset of type 2 diabetes mellitus in susceptible individuals. Biochem Biophys Res Commun. 2015;463(1–2):60–63. doi:10.1016/j.bbrc.2015.05.017
   PubMed Web of Science ®Google Scholar
• Rezk NA, Sabbah NA, Saad MS. Role of microRNA 126 in screening, diagnosis, and prognosis of diabetic patients in Egypt. IUBMB Life. 2016;68(6):452–458. doi:10.1002/iub.1502
   PubMed Web of Science ®Google Scholar
• Tsukita S, Yamada T, Takahashi K, et al. MicroRNAs 106b and 222 improve hyperglycemia in a mouse model of insulin-deficient diabetes via pancreatic β-cell proliferation. EBioMedicine. 2017;15:163–172. doi:10.1016/j.ebiom.2016.12.002
   PubMed Web of Science ®Google Scholar
• Wang -J-J, Zhang Y-T, Tseng YJ, Zhang J. miR-222 targets ACOX1, promotes triglyceride accumulation in hepatocytes. Hepatobiliary Pancreat Dis Int. 2019;18(4):360–365. doi:10.1016/j.hbpd.2019.05.002
   PubMedGoogle Scholar
• Liu L-F, Liang Z, Lv Z-R, et al. MicroRNA-15a/b are up-regulated in response to myocardial ischemia/reperfusion injury. J Geriatr Cardiol. 2012;9(1):28. doi:10.3724/SP.J.1263.2012.00028
   PubMedGoogle Scholar
• Yin K-J, Olsen K, Hamblin M, Zhang J, Schwendeman SP, Chen YE. Vascular endothelial cell-specific microRNA-15a inhibits angiogenesis in hindlimb ischemia. J Biol Chem. 2012;287(32):27055–27064. doi:10.1074/jbc.M112.364414
   PubMedGoogle Scholar
• Gallagher IJ, Scheele C, Keller P, et al. Integration of microRNA changes in vivo identifies novel molecular features of muscle insulin resistance in type 2 diabetes. Genome Med. 2010;2(2):9. doi:10.1186/gm130
   PubMed Web of Science ®Google Scholar
• Leong A, Porneala B, Dupuis J, Florez JC, Meigs JB. Type 2 diabetes genetic predisposition, obesity, and all-cause mortality risk in the US: a multiethnic analysis. Diabetes Care. 2016;39(4):539–546. doi:10.2337/dc15-2080
   PubMedGoogle Scholar
• Association AD. 4. Lifestyle management: standards of medical care in diabetes—2018. Diabetes Care. 2018;41(Supplement 1):S38–S50. doi:10.2337/dc18-S004
   PubMedGoogle Scholar